Association for Multiple Endocrine Neoplasia Disorders

The International NET Cancer Alliance (INCA), in collaboration with pharmaceutical giant, Novartis, conducted a patient survey in 2014 to ascertain the experiences of NET patients around the world.

Almost 2,000 patients responded, including some AMEND members.

Results from the survey were published in the Journal of Global Oncology in June 2016. Click here to read the full online publication.

Click here to visit the INCA / NET Cancer Day website